Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance

26Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Recurrent HCV infection after liver transplantation is universal and sustained clearance of HCV-RNA rarely occurs. The aim of this study was to characterize cell-mediated immunity and cytokine production in HCV-infected patients after liver transplant. The study included 6 pretransplantation patients (PT) and 15 liver transplanted patients, including 5 with spontaneous HCV-RNA clearance (SC group), 5 with sustained virological response after antiviral treatment (SVR group), and 5 no response (NR group). The control group included 5 HCV-RNA negative, anti-HCV negative healthy individuals. This study examines proliferative T-cell response and cytokine production (gamma-interferon and IL-10) after HCV specific and phytohemagglutinin (PHA) stimulation in cultured peripheral blood mononuclear cells (PBMCs) from each group. Multispecific proliferative responses to HCV antigens (mean Stimulation Index; SI) were higher in the SVR group (mean SI 7.4 ± 2) and SC group, as compared with the NR group (P < .05, vs SVR) and PT group (P

Cite

CITATION STYLE

APA

Casanovas-Taltavull, T., Ercilla, M. G., Gonzalez P., C. P., Gil, E., Viñas, O., Cañas, C., … Casais, L. A. (2004). Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance. Liver Transplantation, 10(5), 584–594. https://doi.org/10.1002/lt.20105

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free